PARD (Poniard Pharmaceuticals) Dividends per Share: $0.00 (TTM As of Sep. 2011)


What is Poniard Pharmaceuticals Dividends per Share?

Poniard Pharmaceuticals PARD Dividends per Share is $0.00 as of Sep. 2011.

Poniard Pharmaceuticals's dividends per share for the three months ended in Sep. 2011 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2011 was $0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2011 was 0.00. As of today, Poniard Pharmaceuticals's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Poniard Pharmaceuticals  (OTCPK:PARD) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Poniard Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Sep. 2011 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2011 )/ EPS without NRI (Q: Sep. 2011 )
=0/ -2.4
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Dividends per Share Related Terms

Poniard Pharmaceuticals Dividends per Share Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Dividends per Share Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PARD vs OBMP, NSPX, ATRX: Dividends per Share Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Dividend Yield % falls into.


Poniard Pharmaceuticals Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of $0.00 mean?
Poniard Pharmaceuticals (PARD) has a Dividends per Share of $0.00 as of Sep. 2011. Dividends per share represents the per-share amount paid as dividends. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Dividends per Share too high?
Poniard Pharmaceuticals' current Dividends per Share is $0.00.
How does Poniard Pharmaceuticals' Dividends per Share compare to OBMP and NSPX?
Poniard Pharmaceuticals' Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Dividends per Share of $0.00. The current Dividends per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Dividends per Share is $0.00 as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.